ArticleMedical oncology (Northwood, London, England)2012

Phase I and pharmacokinetic study of trabectedin 3-hour infusion every three weeks in patients with advanced cancer and alteration of hepatic function.

Beatriz Pardo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.